Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02876588 · ClinicalTrials.gov registry record · NA
Risk of Wrong-Patient Errors With Multiple Records Open
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 3,356
- Enrollment target
NCT02876588: Completed NA study, sponsored by Columbia University.
NCT02876588 is a NA study that has completed, run by Columbia University. The registered enrollment target is 3,356 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (139% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02876588, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,356 participants
- Enrollment target
Study Summary
This study is designed to achieve the following aims: 1. Assess the relationship between the number of records open at the time of placing an order, and the risk of placing an order on the wrong patient. 2. Compare the incidence of wrong-patient orders in a "restricted environment" that limits its providers to only one record open at a time to an "unrestricted environment" where users can open a maximum of four records at once. 3. The results of this study will help inform decisions on how to safely implement EHR systems. 4. The results of this study will inform a larger scale health IT implementation research project evaluating the balance between the wrong-patient error risks and potential efficiency gains of having multiple records open at once, with rigorous research methodologies.
Primary Outcome
The primary analysis included all order sessions performed by clinicians according to their assigned randomization group. The primary outcome was wrong-patient order sessions, defined as order sessions that include at least 1 wrong-patient Retract-and-Reorder (RAR) event. Wrong-patient order sessions were identified using the Wrong-Patient Retract-and-Reorder (RAR) measure. The Wrong-Patient RAR measure uses an electronic query to identify wrong-patient RAR events, defined as one or more orders
Interventions
- OTHER Unrestricted
- OTHER Restricted
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,356 participants |
| Start Date | 2015-10-01 |
| Est. Completion | 2017-04-30 |
| Phase | NA |
What the finished NCT02876588 record still lists
NCT02876588 is an interventional study that assigns participants to a tested intervention. Its 3,356 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (139% higher).
The record links to 0 conditions, and to 2 interventions - of which Unrestricted is the first listed.
NCT02876588 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02876588 about?
NCT02876588 is a clinical study titled "Risk of Wrong-Patient Errors With Multiple Records Open". This study is designed to achieve the following aims: 1. Assess the relationship between the number of records open at the time of placing an order, and the risk of placing an order on the wrong patient. 2. Compare the incidence of wrong-patient orders in a "restricted environment" that limits its ...
What is the current status of trial NCT02876588?
This trial is currently completed. It is a NA study. The enrollment target is 3,356 participants. The study started on 2015-10-01. Estimated completion is 2017-04-30.
What interventions are being tested in trial NCT02876588?
The interventions under investigation include: Unrestricted (OTHER), Restricted (OTHER).
Who is sponsoring clinical trial NCT02876588?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02876588's enrollment target sits among peer trials
3,356 37th of 2000 higher than 1,964 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06880055 · 3,375 participants
Shield Post-Approval Study Protocol
- NCT03474029 · 3,400 participants · Phase 2
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
- NCT07142954 · 3,400 participants · Phase 3
Epidemiology and Biomarker Study in Alzheimer's Disease
- NCT03674307 · 3,306 participants · NA
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI